Kitanotatsujin Corp
TSE:2930
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kitanotatsujin Corp
TSE:2930
|
JP |
|
ImmunoCellular Therapeutics Ltd
OTC:IMUC
|
US |
|
D
|
Dongkuk Industries Co Ltd
KOSDAQ:005160
|
KR |
|
Q
|
Quart Development SA
WSE:QRT
|
PL |
|
Terra Systems Inc
OTC:TSYI
|
US |
|
Monarch Networth Capital Ltd
BSE:511551
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Kitanotatsujin Corp's stock price target?
Not Available
Kitanotatsujin Corp does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Kitanotatsujin Corp?
Projected CAGR
35%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is 35%.
What is the Gross Profit forecast for Kitanotatsujin Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 2 years is 14%.
What is the Pre-Tax Income forecast for Kitanotatsujin Corp?
Projected CAGR
39%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 2 years is 39%.
What is the Net Income forecast for Kitanotatsujin Corp?
Projected CAGR
42%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 2 years is 42%.
